CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 8-K Event Other events
- 4 Option exercise President and CEO acquired 24,000 shares (option exercise)
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 5,359 shares at $38.18 ($204,607)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 3,640 shares
- 4 Shares withheld for taxes President and CEO gave up 12,636 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 3,918 shares
- 4 Grant or award Director acquired 5,130 shares (grant or award)
- 4 Grant or award Director acquired 5,130 shares (grant or award)
- 4 Grant or award Director acquired 5,130 shares (grant or award)
- 4 Grant or award Director acquired 5,130 shares (grant or award)
- 4 Grant or award President and CEO acquired 149,800 shares (grant or award)
- 4 Grant or award Director acquired 5,130 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 41,088 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 31,779 shares (grant or award)
Page 8 of 36 · 707 filings